This analysis revealed that alternative transcripts in the CML CD34+CD38−ALDHhigh cells, when compared to normal counterparts, were enriched in cellular proliferation genes, p53 signaling pathway, and kinase binding genes. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.